Back to results
US 11,534,414 B2Granted
Bupropion as a modulator of drug activity
AssigneeAntecip Bioventures II LLC
InventorHerriot Tabuteau
Life of this patent
Estimating the term…
Abstract
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Claims21
A dosage form comprising:
- about 100 mg to about 110 mg of bupropion hydrochloride, or a molar equivalent amount of a bupropion in the free base form or another salt form;
- and
- about 40 mg to about 50 mg of dextromethorphan hydrobromide, or a molar equivalent amount of a dextromethorphan in the free base form or another salt form;
- and
- wherein the dextromethorphan and the bupropion are in separate domains or phases within the dosage form.
2 more elements
A dosage form comprising:
- about 200 mg to about 220 mg of bupropion hydrochloride, or a molar equivalent amount of a bupropion in the free base form or another salt form;
- and
- about 80 mg to about 100 mg of dextromethorphan hydrobromide, or a molar equivalent amount of a dextromethorphan in the free base form or another salt form;
- and
- wherein the dextromethorphan and the bupropion are in separate domains or phases within the dosage form.
2 more elements
Dependencies are inferred from the claim text.